Published in Psychiatry Res on November 29, 1999
Anodal transcranial direct current stimulation of prefrontal cortex enhances working memory. Exp Brain Res (2005) 3.44
Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci (2005) 1.30
Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm (Vienna) (2009) 1.22
Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? Neuropharmacology (2012) 1.19
Advances in the treatment of depression. NeuroRx (2006) 1.03
Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review. Brain Stimul (2010) 0.96
Improved language in a chronic nonfluent aphasia patient after treatment with CPAP and TMS. Cogn Behav Neurol (2010) 0.94
Research with rTMS in the treatment of aphasia. Restor Neurol Neurosci (2010) 0.94
"Getting physical": the management of neuropsychiatric disorders using novel physical treatments. Neuropsychiatr Dis Treat (2006) 0.92
Acute effects of repetitive transcranial magnetic stimulation on attentional control are related to antidepressant outcomes. J Psychiatry Neurosci (2009) 0.83
The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people. Philos Trans R Soc Lond B Biol Sci (2015) 0.83
Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression - an open label trial. Neuropsychiatr Dis Treat (2007) 0.81
Neurocognitive effects of repetitive transcranial magnetic stimulation in adolescents with major depressive disorder. Front Psychiatry (2013) 0.79
Repetitive transcranial magnetic stimulation for the treatment of depression. J Psychiatry Neurosci (2005) 0.79
More female patients and fewer stimuli per session are associated with the short-term antidepressant properties of repetitive transcranial magnetic stimulation (rTMS): a meta-analysis of 54 sham-controlled studies published between 1997-2013. Neuropsychiatr Dis Treat (2014) 0.79
Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis. Ont Health Technol Assess Ser (2004) 0.77
Short-term efficacy of repetitive transcranial magnetic stimulation (rTMS) in depression- reanalysis of data from meta-analyses up to 2010. BMC Psychol (2014) 0.77
Repetitive transcranial magnetic stimulation in psychiatry. Ann Indian Acad Neurol (2011) 0.76
Efficacy of repetitive transcranial magnetic stimulation with quetiapine in treating bipolar II depression: a randomized, double-blinded, control study. Sci Rep (2016) 0.75
No change in neuropsychological functioning after receiving repetitive transcranial magnetic stimulation treatment for major depression. J ECT (2014) 0.75
Transcranial magnetic stimulation: a new tool in the fight against depression. Dialogues Clin Neurosci (2002) 0.75
Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Adult and Youth Populations: A Systematic Literature Review and Meta-Analysis. Prim Care Companion CNS Disord (2015) 0.75
A novel coil array for combined TMS/fMRI experiments at 3 T. Magn Reson Med (2014) 0.75
The effects of high-frequency rTMS over the left DLPFC on cognitive control in young healthy participants. PLoS One (2017) 0.75
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Human mitochondrial DNA variation and evolution: analysis of nucleotide sequences from seven individuals. Genetics (1983) 9.22
Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet (1997) 4.86
Intraspecific nucleotide sequence variability surrounding the origin of replication in human mitochondrial DNA. Gene (1983) 4.47
Mutant and native human beta-amyloid precursor proteins in transgenic mouse brain. Neurobiol Aging (1996) 3.38
Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry (1997) 3.02
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet (1996) 2.93
Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet (2001) 2.77
Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol (1998) 2.55
Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet (1987) 2.42
Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet (1996) 2.40
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A (2001) 2.38
The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord (1999) 2.30
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol (2000) 2.23
Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet (1996) 2.18
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 2.12
Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science (1992) 2.12
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry (2003) 2.12
Body size and dispersal mode as key traits determining metacommunity structure of aquatic organisms. Ecol Lett (2012) 1.88
Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Mol Genet (2000) 1.84
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78
A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging (2000) 1.78
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population. Am J Hum Genet (2002) 1.77
A genetic association for cigarette smoking behavior. Health Psychol (1999) 1.69
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment. Brain (2006) 1.62
Social functioning in depression: a review. J Clin Psychiatry (2000) 1.62
Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF. Neurology (2000) 1.60
SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry (2004) 1.60
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology (2002) 1.58
Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. Neurology (2001) 1.58
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry (2008) 1.54
Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry (2000) 1.53
Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia (2001) 1.53
Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue. J Neurochem (1993) 1.52
Effects of aging on default mode network activity in resting state fMRI: does the method of analysis matter? Neuroimage (2010) 1.52
CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease. Mol Neurobiol (2002) 1.51
Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J Neurosci (1998) 1.50
Combined action of the ACE D- and the G-protein beta3 T-allele in major depression: a possible link to cardiovascular disease? Mol Psychiatry (2002) 1.49
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology (2007) 1.43
D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. J Psychopharmacol (2000) 1.39
[New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?]. Dtsch Med Wochenschr (2005) 1.39
Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem (1998) 1.36
Yeast 2-micrometer plasmid DNA replication in vitro: origin and direction. Proc Natl Acad Sci U S A (1981) 1.36
Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry (1999) 1.33
Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett (2000) 1.31
Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques. Proc Natl Acad Sci U S A (1990) 1.31
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
Enhanced amyloidogenic processing of the beta-amyloid precursor protein in gene-targeted mice bearing the Swedish familial Alzheimer's disease mutations and a "humanized" Abeta sequence. J Biol Chem (1996) 1.30
Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior. Mol Psychiatry (2000) 1.29
Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. J Neurosci (1991) 1.27
Comparative efficacy of antidepressants. Drugs (1992) 1.25
Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med (2011) 1.25
Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry (2006) 1.24
Nucleotide sequence of the gene encoding human atrial natriuretic factor precursor. Nature (1985) 1.23
Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord (2004) 1.22
Genetic testing for cancer predisposition. Annu Rev Med (2001) 1.21
Sapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet (2009) 1.21
A phase II study of paclitaxel, weekly, 24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer. Br J Cancer (2000) 1.19
Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet (2000) 1.18
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease. Ann Neurol (2001) 1.18
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing. Exp Neurol (2009) 1.17
Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs. Transfusion (2001) 1.17
Menstrual cycle effects on cortical excitability. Neurology (1999) 1.17
A beta 42 is the predominant form of amyloid beta-protein in the brains of short-term survivors of head injury. Neuroreport (1997) 1.15
Interstitial deletion of the long arm of chromosome no. 7 (7q-) in an infant with multiple anomalies. Clin Genet (1976) 1.14
Panic and fear induced by deep brain stimulation. J Neurol Neurosurg Psychiatry (2006) 1.13
Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease. Brain Res (1993) 1.13
Expression patterns of beta-amyloid precursor protein (beta-APP) in neural and nonneural human tissues from Alzheimer's disease and control subjects. Ann Neurol (1991) 1.12
[Psychometric evaluation of the German version of the Barratt Impulsiveness Scale]. Nervenarzt (2008) 1.12
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. J Med Genet (2008) 1.11
CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease. Eur J Neurol (2008) 1.10
Multicenter assessment of reliability of cranial MRI. Neurobiol Aging (2005) 1.08
The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci (1998) 1.08
Novel beta-secretase cleavage of beta-amyloid precursor protein in the endoplasmic reticulum/intermediate compartment of NT2N cells. J Cell Biol (1997) 1.07
Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder. Int Clin Psychopharmacol (1999) 1.07
Correlation between patient weight and defects in DNA mismatch repair: is this the link between an increased risk of previous cancer in thinner women with endometrial cancer? Int J Gynecol Cancer (2007) 1.07
[Help-seeking behavior and compliance of suicidal patients]. Psychiatr Prax (1984) 1.06
Assignment of a polymorphic polypeptide to the human mitochondrial DNA unidentified reading frame 3 gene by a new peptide mapping strategy. J Biol Chem (1983) 1.06
Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport (2000) 1.06
Treatment of depression by obstetrician-gynecologists: a survey study. Obstet Gynecol (1997) 1.06
[Transcranial magnetic stimulation. A diagnostic means from neurology as therapy in psychiatry?]. Nervenarzt (1997) 1.06
Motor cortex excitability correlates with an anxiety-related personality trait. Biol Psychiatry (2001) 1.05
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment. J Nutr Health Aging (2009) 1.04
Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry (2006) 1.04
A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. Am J Med Genet B Neuropsychiatr Genet (2009) 1.03
Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis. Neurogenetics (1997) 1.02
Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett (2001) 1.01
Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Neurobiol Aging (2002) 1.01
Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology. J Nutr Health Aging (2012) 1.00
What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review? Bipolar Disord (2008) 1.00
Molecular features of hypothalamic plaques in Alzheimer's disease. Am J Pathol (1991) 1.00